Advertisement

Topics

Hemophilia Federation of America Company Profile

11:39 EST 14th December 2018 | BioPortfolio


News Articles [331 Associated News Articles listed on BioPortfolio]

ASH to Collaborate on Clinical Practice Guidelines on Diagnosis and Management of von Willebrand Disease

WASHINGTON, June 21, 2018 /PRNewswire-USNewswire/ — The American Society of Hematology (ASH) will collaborate with the International Society on Thrombosis and Haemostasis (ISTH), National Hemoph...

ASH to collaborate on clinical practice guidelines of von Willebrand Disease

(American Society of Hematology) The American Society of Hematology (ASH) will collaborate with the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), Wo...

ASH to collaborate on clinical practice guidelines on von Willebrand Disease

(American Society of Hematology) The American Society of Hematology (ASH) will collaborate with the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), Wo...

BIVV001 Phase 1/2a Data Presented at ASH Underscore Potential for Once Weekly Dosing with Sustained High Factor Levels in Hemophilia A

Early data (n=2) show an unprecedented half-life of 44 hours with a single 65 IU/kg dose of BIVV001, significantly longer than the half-life observed with a short-acting recombina...

BioMarin Sponsors Off-Broadway Show About Hemophilia

'Hemophilia: The Musical' allows teens to share their experiences with the genetic disease.

STAT Plus: Wall Street is writing off Spark’s hemophilia gene therapy. Clinicians are not

Wall Street pummeled Spark Therapeutics after seeing new data on its experimental gene therapy for hemophilia. Three physicians who treat hemophilia patients saw things a little differently.

Despite new approval, Bayer continues to face hemophilia headwinds

A terminated distribution partnership and stiffening market competition are threats to the German drugmaker's hemophilia business.

FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom

The treatment landscape for hemophilia is changing fast, and today marks a turning point. The FDA has just cleared Roche to sell its drug emicizumab (Hemlibra) to patients with any form of hemophilia ...

Drugs and Medications [244 Associated Drugs and Medications listed on BioPortfolio]

Antimicrobial [Safetec of America]

Antimicrobial

A.b.h.c. instant hand sanitizer citrus scent [Safetec of America, Inc.]

A.B.H.C. INSTANT HAND SANITIZER

Hydrocortisone [Safetec of America, Inc.]

Safetec First Aid 1% Hydrocortisone Cream

Analgesic [Safetec of America, Inc.]

Safetec of America, Inc. PAIN SPRAY

Antiseptic [Safetec of America]

ANTISEPTIC – Benzalkonium chloride liquid Safetec of America

PubMed Articles [832 Associated PubMed Articles listed on BioPortfolio]

Haemophilia care in Latin America: Assessment and perspectives.

The study is the first application of the Principles of Haemophilia Care for Europe (PHCE) in other regions of the world, specifically in Latin America.

rFIXFc for Immune Tolerance Induction in a Severe Hemophilia B Patient with an Inhibitor and Prior History of ITI Related Nephrotic Syndrome.

Miracle of haemophilia drugs: Personal views about a few main players.

In the second decade of the third millennium there have been dramatic developments pertaining to the availability of highly innovative drugs for hemophilia care, notwithstanding a satisfactory previou...

Value of prophylaxis vs on-demand treatment: Application of a value framework in hemophilia.

Therapeutic advances over the past 30 years have led to longer life expectancy and improved quality of life (QOL) for persons with hemophilia. Access to innovative therapy may be compromised if treat...

Factor XI and pulmonary infections.

Clinical Trials [662 Associated Clinical Trials listed on BioPortfolio]

Study Evaluating ReFacto in Hemophilia A

To identify the causative mutations in previously untreated patients with hemophilia A enrolled in the ReFacto® clinical safety and efficacy study CTN 93-R833-0XX/C9741-28, using two esta...

Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

This trial is conducted in Africa, Asia, Europe, South America, and the United States of America (USA). The purpose of this study is to evaluate the effectiveness of secondary prophylacti...

ATHN 7: Hemophilia Natural History Study

This is a real-world study of the safety of the treatments used for people with hemophilia. The study will follow people with hemophilia A or B from across the country for about 4 years as...

Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B

Retrospective, multicenter study in patients with hemophilia B. This study will be placed at 20 to 50 hemophilia treatment centers in North America and the EU, and is designed to estimate...

World Bleeding Disorders Registry

The World Federation of Hemophilia (WFH) is conducting the pilot phase of an international, retrospective and prospective, observational, World Bleeding Disorders Registry (WBDR). This pil...

Companies [1062 Associated Companies listed on BioPortfolio]

World Federation of Hemophilia (WFH)

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and related bleeding disorders. Established in 1963,...

Hemophilia Federation of America

World Federation of Hemophilia

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and other inherited bleeding di...

NORSK INDUSTRI

On 28. November 2005 the new organisation Federation of Norwegian Industries was established. The new Federation will be formally operative as of 1. January 2006. From the start, the Federation of Nor...

The National Hemophilia Foundation

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education,...

More Information about "Hemophilia Federation of America" on BioPortfolio

We have published hundreds of Hemophilia Federation of America news stories on BioPortfolio along with dozens of Hemophilia Federation of America Clinical Trials and PubMed Articles about Hemophilia Federation of America for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hemophilia Federation of America Companies in our database. You can also find out about relevant Hemophilia Federation of America Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record